LON:ARIX Arix Bioscience (ARIX) Share Price, News & Analysis → Grab Your Free Bitcoin Today! (From Crypto Swap Profits) (Ad) Free ARIX Stock Alerts GBX 142 0.00 (0.00%) (As of 02/12/2024) Add Compare Share Share Today's Range 142▼ 14250-Day Range 135.50▼ 144.5052-Week Range 97▼ 145Volume377,046 shsAverage Volume636,934 shsMarket Capitalization£183.73 millionP/E Ratio1,290.91Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades Get Arix Bioscience alerts: Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About Arix Bioscience Stock (LON:ARIX)Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.Read More ARIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ARIX Stock News HeadlinesMarch 22, 2024 | msn.comLife sciences firm ReNeuron which received £13m in Welsh Government support enters administrationMarch 18, 2024 | seekingalpha.comAcacia Research: Positive Developments, Discount To Book Value High Despite Recent Price SpikeMarch 29, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionMarch 15, 2024 | finance.yahoo.comAcacia Research Corporation (NASDAQ:ACTG) Q4 2023 Earnings Call TranscriptFebruary 12, 2024 | markets.businessinsider.comSuspension of Trading in SharesJanuary 9, 2024 | finanznachrichten.deArix Bioscience PLC: Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)January 8, 2024 | finanznachrichten.deArix Bioscience PLC: Portfolio company Harpoon Therapeutics to be -3-January 8, 2024 | finance.yahoo.comWith 40% ownership, Arix Bioscience plc (LON:ARIX) has piqued the interest of institutional investorsMarch 29, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionJanuary 5, 2024 | finanznachrichten.deArix Bioscience PLC: Publication of Circular and RTW Bio Prospectus -2-January 5, 2024 | markets.businessinsider.comPublication of Circular and RTW Bio ProspectusDecember 22, 2023 | finanznachrichten.deArix Bioscience PLC: Update regarding timing of Proposed Scheme of ReconstructionDecember 22, 2023 | markets.businessinsider.comUpdate regarding timing of Proposed Scheme of ReconstructionDecember 8, 2023 | markets.businessinsider.comPortfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass TrialDecember 4, 2023 | thetimes.co.ukThorny case for Arix chief to answerNovember 19, 2023 | thetimes.co.ukArix Bioscience board’s Caribbean meeting left shareholders ‘flabbergasted’November 15, 2023 | finanznachrichten.deCorrection: Portfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockNovember 14, 2023 | finance.yahoo.comAcacia Research Corporation (NASDAQ:ACTG) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | finance.yahoo.comQ3 2023 Acacia Research Corp Earnings CallNovember 13, 2023 | finance.yahoo.comAcacia Research Corp (ACTG) Reports Mixed Q3 Results Amid Strategic ShiftsNovember 12, 2023 | msn.comBroker Peel Hunt Ditches Arix Over Terms of Takeover DealNovember 10, 2023 | thetimes.co.ukBroker quits Arix over RTW takeoverNovember 9, 2023 | thetimes.co.ukDon’t swallow dog’s breakfast deal at Arix BioscienceNovember 5, 2023 | morningstar.comArix Bioscience PLC ARIXNovember 2, 2023 | thetimes.co.ukAmerican investment firm swoops for Arix BioscienceNovember 1, 2023 | markets.businessinsider.comPortfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102November 1, 2023 | finanznachrichten.deArix Bioscience PLC: Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102See More Headlines Receive ARIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arix Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:ARIX CUSIPN/A CIKN/A Webarixbioscience.com Phone+44-20-72901050FaxN/AEmployees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.11 Trailing P/E Ratio1,290.91 Forward P/E Ratio3.70 P/E GrowthN/ANet Income£14.96 million Net Margins105.64% Pretax MarginN/A Return on Equity6.41% Return on Assets2.18% Debt Debt-to-Equity Ratio0.01 Current Ratio73.10 Quick Ratio117.67 Sales & Book Value Annual Sales£14.16 million Price / Sales12.98 Cash FlowGBX 136.32 per share Price / Cash Flow1.04 Book ValueGBX 192 per share Price / Book0.74Miscellaneous Outstanding Shares129,390,000Free FloatN/AMarket Cap£183.73 million OptionableNot Optionable Beta1.05 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Tom DavidsonCOO & CFOMs. Laura CraigInvestor Relations OfficerDr. Tassos Konstantinou Ph.D.Managing DirectorMs. Jade FletcherFinancial ControllerMr. Felix Breyer Ph.D.AssociateMr. Roy Bartel-Taverner M.D.AnalystMore ExecutivesKey CompetitorsOxford BiomedicaLON:OXBhVIVOLON:HVOAvacta GroupLON:AVCTCircassia GroupLON:CIRVerona Pharma plc (VRP.L)LON:VRPView All CompetitorsInsidersAndrew SmithBought 25,000 shares on 11/9/2023Total: £2.83 M ($113.00/share)Peregrine D E M MoncreiffeBought 60,000 shares on 11/2/2023Total: £6.90 M ($115.00/share)Debra BarkerBought 26,000 shares on 5/3/2023Total: £2.76 M ($106.00/share)View All Insider Transactions ARIX Stock Analysis - Frequently Asked Questions How have ARIX shares performed in 2024? Arix Bioscience's stock was trading at GBX 126 at the beginning of the year. Since then, ARIX shares have increased by 12.7% and is now trading at GBX 142. View the best growth stocks for 2024 here. How do I buy shares of Arix Bioscience? Shares of ARIX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:ARIX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arix Bioscience plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.